Concepedia

Sandra Henein

SH

7

Publications

294

Citations

7

H-Index

2016

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Sanofi (United States)

Sandra Henein is an author at University of North Carolina at Chapel Hill specializing in vaccine development, medicine, and humoral immunity.

ORCID

Top concepts

Publications per year

2016–2023

7

Publications

7

Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals

Sandra Henein, Jesica Swanstrom, Anthony M. Byers et al. · The Journal of Infectious Diseases · 2016 · 123 citations · Full text

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)

Laura White, Ellen Young, Mark Stoops et al. · PLoS neglected tropical diseases · 2021 · 64 citations · Full text

, , +11

Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection

Sandra Henein, Cameron Adams, Matthew Bonaparte et al. · Journal of Clinical Investigation · 2021 · 42 citations · Full text

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate

Jesica Swanstrom, Sandra Henein, Jessica A. Plante et al. · The Journal of Infectious Diseases · 2018 · 29 citations · Full text

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity

Ellen Young, Boyd L. Yount, Petraleigh Pantoja et al. · Nature Communications · 2023 · 16 citations · Full text

Rows per page

1–5 of 7